May 6 at 12 p.m. ET
Former FDA Commissioner Dr. Scott Gottlieb and former White House Health Policy Advisor Dr. Zeke Emanuel joined The Washington Post Live to discuss the latest developments in creating a coronavirus vaccine, the status of anti-body testing and anti-viral treatment and what medical requirements the U.S. needs to meet to safely reopen.
Highlights
Former FDA Commissioner Dr. Scott Gottlieb said he thinks we’re going to have enough vaccine to run large-scale studies in the fall if everything goes as planned.
  • May 6
Dr. Zeke Emanuel says he thinks it’s possible we’ll see a coronavirus vaccine in 12 months, but he doesn’t believe it would be widely available in the United States in that time period. “I’m looking at the fall 2021, maybe January 2022. I think that’s when we’re very likely to have it, and it’s going to be widely distributed.”
  • May 6
When asked what public health issues he believes presumptive Democratic presidential candidate Joe Biden would need to address if he’s elected, Dr. Zeke Emanuel said the production and distribution of a vaccine would be a ‘Day 1’ priority. “We’re going to have to focus on the production and distribution of a vaccine... and figuring out how to restructure our health care system so we do not have this problem again.”
  • May 6
President Trump announced Wednesday morning that the White House Coronavirus Task Force will continue its work indefinitely. Former FDA Commissioner Dr. Scott Gottlieb, who has served as an informal adviser to the White House, says he believes the task force will begin to focus on a vaccine and therapeutics. “You’re going to see an increasing emphasis on trying to bring more organization and leadership around the development of therapeutics…The things that government can affect here, which is trying to bring more coordination around clinical development…scale-up of manufacturing. I think the more likely we are to do these things in parallel, the more likely we are to be able to secure sufficient doses of a vaccine in time, if we’re able to get one to the market that is safe and effective.”
  • May 6
The FDA recently issued an emergency use authorization for the antiviral drug remdesivir for the treatment of coronavirus patients. Dr. Zeke Emanuel said the drug only helps shorten the recovery time for patients, adding that what we need is a drug that can treat the virus. ‘What we really need are drugs designed for covid-19 disease, and those are going to take longer…For a lot of these viruses …we need more than one drug.”
  • May 6
Dr. Scott Gottlieb
Former FDA Commissioner
Dr. Scott Gottlieb served as the 23rd Commissioner of Food and Drugs on May 11, 2017 to April 5, 2019. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner. He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.
Dr. Zeke Emanuel
Vice Provost for Global Initiatives, University of Pennsylvania
Ezekiel J. Emanuel is the Vice Provost for Global Initiatives, the Diane v.S. Levy and Robert M. Levy University Professor, and Co-Director of the Healthcare Transformation Institute at the University of Pennsylvania. From January 2009 to January 2011, Dr. Emanuel served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. Prior to that he was the founding chair of the Department of Bioethics at the National Institutes of Health from 1997 to August of 2011. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. He has published over 300 articles mainly on health care reform, research ethics, and end of life care. He has also authored or edited 15 books. His new book entitled Which Country Has the World’s Best Health Care? Will be published in June. Dr. Emanuel is the most widely cited bioethicist in history.
Interviewed by Frances Stead Sellars
The Washington Post
About Washington Post Live
Washington Post Live is the newsroom’s live journalism platform. Top-level government and business leaders, emerging voices and newsmakers discuss the most pressing national and global issues of the day.